Section 2: Selection, Procurement and Distribution

2SPD-007

COST-MINIMISATION ANALYSIS OF LUNG CANCER PD-L1 POSITIVE TREATMENT

2SPD-006

ECONOMIC IMPACT OF INLFLIXIMAB BIOSIMILAR REFERENCING IN THE HOSPITAL

2SPD-005

ECONOMICAL ANALYSIS OF TENOFOVIR ALAFENAMIDE VERSUS TENOFOVIR-DISOPROXIL FURAMATE

2SPD-004

DRUG CONSUMPTION DATA FOR GUIDING ANTIBIOTIC USE RATIONALISATION IN A SURGICAL DEPARTMENT

2SPD-003

MONITORING THE USE OF LINEZOLID IN A THIRD-LEVEL HOSPITAL

2SPD-002

COMPARATIVE EFFICACY OF DIMETHYLFUMARATE AND OTHER TREATMENTS FOR MODERATE-TO-SEVERE CHRONIC PLAQUE PSORIASIS

2SPD-001

DESCRIBING A THICKENER HOME DELIVERY PROTOCOL AND THE BENEFITS OF ITS IMPLEMENTATION

2SPD-029

IMPACT OF THE IMPLEMENTATION OF THE FALSIFIED MEDICINES DIRECTIVE ON A HEALTHCARE INSTITUTION

2SPD-027

CENTRALISED PURCHASING AS A STRATEGIC LINE FOR THE RATIONALISATION OF PHARMACEUTICAL EXPENDITURE IN A REGIONAL HEALTH SERVICE

2SPD-026

MEDICINES’ SHORTAGE AND HOSPITAL PHARMACISTS’ STRATEGIES

2SPD-025

PRACTICAL CLASSIFICATION OF MEDICAL DEVICES BASED ON ANATOMICAL SYSTEMS AND CREATION OF AN ELECTRONIC GUIDE FOR USERS IN A TEACHING HOSPITAL

2SPD-023

IMPROVEMENTS IN WARD PHARMACY MANAGEMENT BY PHARMACEUTICAL STAFF

2SPD-022

EVALUATION OF THE IMPLEMENTATION OF A CENTRALISED FLOOR STOCK: WHAT CONCLUSIONS CAN BE DRAWN?

2SPD-017

THE REVIEW AND CLASSIFICATION OF THE MOST COMMONLY USED SURGICAL SUTURES

2SPD-016

IMPLANTABLE MEDICAL DEVICES MANAGEMENT: A CHALLENGE

Pages